Revealing on April 30: Are You Ready for the Upcoming Election Surprise?
Here is the latest financial fact sheet of ORTIN LABS . For more details, see the ORTIN LABS quarterly results and ORTIN LABS share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | -1.5 |
No. of shares | m | 8.13 |
1 Week | % | 1.5 |
1 Month | % | 15.5 |
1 Year | % | 1.1 |
52 week H/L | Rs | 30.3/16.2 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
ORTIN LABS EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 24 | 17 | 35 | 52 | 32 | |
Low | Rs | 12 | 7 | 7 | 22 | 17 | |
Sales per share (Unadj.) | Rs | 99.0 | 116.5 | 10.0 | 10.1 | 7.4 | |
Earnings per share (Unadj.) | Rs | 0.8 | -0.3 | 1.2 | -0.5 | -0.1 | |
Diluted earnings per share | Rs | 1.6 | -0.7 | 1.2 | -0.5 | -0.1 | |
Cash flow per share (Unadj.) | Rs | 1.8 | 0.8 | 1.5 | -0.1 | 0.2 | |
Dividends per share (Unadj.) | Rs | 0 | 0 | 0 | 0 | 0 | |
Adj. dividends per share | Rs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Avg Dividend yield | % | 0 | 0 | 0 | 0 | 0 | |
Book value per share (Unadj.) | Rs | 14.8 | 14.1 | 14.0 | 13.5 | 13.4 | |
Adj. book value per share | Rs | 30.9 | 29.3 | 14.0 | 13.5 | 13.4 | |
Shares outstanding (eoy) | m | 16.94 | 16.94 | 8.13 | 8.13 | 8.13 | |
Price / Sales ratio | x | 0.2 | 0.1 | 2.1 | 3.7 | 3.3 | |
Avg P/E ratio | x | 23.5 | -36.3 | 18.0 | -75.3 | -209.6 | |
P/CF ratio (eoy) | x | 9.9 | 14.7 | 13.8 | -286.1 | 125.2 | |
Price / Book Value ratio | x | 1.2 | 0.9 | 1.5 | 2.7 | 1.8 | |
Dividend payout | % | 0 | 0 | 0 | 0 | 0 | |
Avg Mkt Cap | Rs m | 301 | 205 | 170 | 300 | 196 | |
Total wages/salary | Rs m | 37 | 47 | 9 | 7 | 7 |
ORTIN LABS INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 1,678 | 1,974 | 82 | 82 | 60 | |
Other income | Rs m | 6 | 2 | 1 | 2 | 0 | |
Total revenues | Rs m | 1,683 | 1,976 | 82 | 84 | 61 | |
Gross profit | Rs m | 62 | 57 | 12 | 4 | 5 | |
Depreciation | Rs m | 18 | 20 | 3 | 3 | 3 | |
Interest | Rs m | 32 | 32 | 9 | 8 | 4 | |
Profit before tax | Rs m | 18 | 7 | 1 | -5 | -1 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 6 | 13 | -8 | -1 | 0 | |
Profit after tax | Rs m | 13 | -6 | 9 | -4 | -1 | |
Gross profit margin | % | 3.7 | 2.9 | 15.2 | 4.6 | 8.2 | |
Effective tax rate | % | 30.4 | 178.4 | -594.9 | 24.8 | 15.2 | |
Net profit margin | % | 0.8 | -0.3 | 11.6 | -4.8 | -1.6 |
ORTIN LABS BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 820 | 924 | 61 | 58 | 65 | |
Current liabilities | Rs m | 722 | 838 | 79 | 76 | 70 | |
Net working cap to sales | % | 5.9 | 4.3 | -21.6 | -22.6 | -7.4 | |
Current ratio | x | 1.1 | 1.1 | 0.8 | 0.8 | 0.9 | |
Inventory Days | Days | 3 | 2 | 15 | 14 | 16 | |
Debtors Days | Days | 823 | 68,700,189 | 174,959,293 | 1,435 | 2,072 | |
Net fixed assets | Rs m | 230 | 241 | 151 | 150 | 147 | |
Share capital | Rs m | 169 | 169 | 81 | 81 | 81 | |
"Free" reserves | Rs m | 82 | 69 | 32 | 28 | 27 | |
Net worth | Rs m | 251 | 238 | 114 | 110 | 109 | |
Long term debt | Rs m | 47 | 49 | 14 | 17 | 30 | |
Total assets | Rs m | 1,051 | 1,165 | 213 | 207 | 212 | |
Interest coverage | x | 1.6 | 1.2 | 1.2 | 0.3 | 0.7 | |
Debt to equity ratio | x | 0.2 | 0.2 | 0.1 | 0.2 | 0.3 | |
Sales to assets ratio | x | 1.6 | 1.7 | 0.4 | 0.4 | 0.3 | |
Return on assets | % | 4.3 | 2.3 | 8.6 | 2.0 | 1.4 | |
Return on equity | % | 5.1 | -2.4 | 8.3 | -3.6 | -0.9 | |
Return on capital | % | 16.9 | 13.7 | 7.9 | 2.2 | 2.1 | |
Exports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Imports to sales | % | 0.6 | 0 | 0 | 0 | 0 | |
Exports (fob) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Imports (cif) | Rs m | 9 | 0 | 0 | 0 | 0 | |
Fx inflow | Rs m | 0 | 0 | 0 | 0 | 0 | |
Fx outflow | Rs m | 9 | 0 | 0 | 0 | 0 | |
Net fx | Rs m | -9 | 0 | 0 | 0 | 0 |
ORTIN LABS CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 65 | 33 | 180 | 21 | -3 | |
From Investments | Rs m | -33 | -31 | 1 | -1 | 0 | |
From Financial Activity | Rs m | -29 | -13 | -99 | -5 | 9 | |
Net Cashflow | Rs m | 4 | -11 | 82 | 16 | 7 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: J R K Panduranga Rao | COMP SEC: Divya Purswani | YEAR OF INC: 1986 | BSE CODE: 539287 | FV (Rs): 10 | DIV YIELD (%): - |
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Compare ORTIN LABS With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
After opening the day on high, Indian share markets continued the momentum as the session progressed and ended the higher.